# Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C

> **NCT00917358** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 42 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Pegylated interferon alfa-2a

## Key facts

- **NCT ID:** NCT00917358
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2012-12-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00917358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00917358, "Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00917358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*